Related Experiment Video

Updated: Jun 5, 2026

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
08:26

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Published on: April 12, 2018

The von Hippel-Lindau Tumor Suppressor Protein Is Destabilized by Src: Implications for Tumor Angiogenesis and

Mary T-H Chou1, Josephine Anthony, Jeffrey D Bjorge

  • 1Department of Biochemistry and Molecular Biology, and Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada.

Genes & Cancer
|January 8, 2011
PubMed

Insights

Src kinase destabilizes the von Hippel-Lindau (VHL) tumor suppressor protein, promoting cancer progression. This mechanism involves VHL degradation, leading to increased hypoxia-inducible factor-1α and vascular endothelial growth factor production.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The von Hippel-Lindau (VHL) tumor suppressor protein is crucial for regulating cellular oxygen sensing pathways.
  • Mutations in VHL are linked to renal and central nervous system cancers.
  • VHL targets hypoxia-inducible factor-1α (HIF-1α) for degradation, a key regulator of vascular endothelial growth factor (VEGF).

Purpose of the Study:

  • To investigate the role of Src kinase in VHL protein stability.
  • To explore the implications of Src-mediated VHL destabilization in cancer, including breast cancer.
  • To elucidate the molecular mechanism linking Src, VHL, and VEGF production.

Main Methods:

  • Investigated VHL protein stability under conditions of elevated Src kinase activity.
  • Analyzed the phosphorylation status of VHL, specifically tyrosine residue 185.
  • Assessed ubiquitination and proteasomal degradation of VHL.
  • Measured HIF-1α levels and VEGF production.

Main Results:

  • Elevated Src kinase induces VHL destabilization and degradation, even under normoxic conditions.
  • Src-mediated VHL degradation occurs via phosphorylation of VHL at tyrosine 185, followed by ubiquitination and proteasomal degradation.
  • VHL degradation by Src leads to increased HIF-1α accumulation and enhanced VEGF production.
  • This pathway is implicated in promoting tumor angiogenesis and cancer progression.

Conclusions:

  • Src kinase destabilizes VHL protein, contributing to cancer development.
  • Src-induced VHL degradation promotes angiogenesis via the HIF-1α/VEGF pathway.
  • Targeting the Src-VHL interaction may offer therapeutic strategies for VHL-associated and other cancers.

More Related Videos

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis10:56

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Published on: August 1, 2019

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...